Luc G T Morris

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc The increasing incidence of thyroid cancer: the influence of access to care
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Thyroid 23:885-91. 2013
  2. ncbi request reprint Predictors of survival and recurrence after temporal bone resection for cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 34:1231-9. 2012
  3. pmc Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 29:739-46. 2011
  4. pmc Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis
    Luc G T Morris
    Head and Neck Service, New York University Cancer Institute, New York, NY, USA
    Am J Surg 200:454-61. 2010
  5. pmc Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Causes Control 22:671-9. 2011
  6. pmc High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 33:824-30. 2011
  7. pmc Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 136:697-701. 2010
  8. doi request reprint Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
    Ian Ganly
    Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program, 1275 York Avenue, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E962-72. 2013
  9. doi request reprint Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer
    Kunal S Jain
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 119:1832-7. 2013
  10. pmc Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
    N Gopalakrishna Iyer
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:4439-46. 2011

Collaborators

Detail Information

Publications24

  1. pmc The increasing incidence of thyroid cancer: the influence of access to care
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Thyroid 23:885-91. 2013
    ..To conclude that overdiagnosis is occurring, evidence for an association between access to health care and the incidence of cancer is necessary...
  2. ncbi request reprint Predictors of survival and recurrence after temporal bone resection for cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 34:1231-9. 2012
    ..The purpose of this study was to identify factors predictive of outcome in patients undergoing temporal bone resection (TBR) for head and neck cancer...
  3. pmc Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 29:739-46. 2011
    ..Our objectives were to identify HNSCC subsite-specific differences in SPM risk and distribution and to describe trends in risk over 3 decades, before and during the era of human papillomavirus (HPV) -associated oropharyngeal SCC...
  4. pmc Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis
    Luc G T Morris
    Head and Neck Service, New York University Cancer Institute, New York, NY, USA
    Am J Surg 200:454-61. 2010
    ..Our objective was to examine trends in the incidence of well-differentiated thyroid cancers with large size and adverse pathological features...
  5. pmc Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Causes Control 22:671-9. 2011
    ..Our objectives were to quantify the excess risk of SPM across all anatomic sites in which SPM risk is meaningfully elevated, including non-HNLE sites, in a large cohort of US patients...
  6. pmc High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 33:824-30. 2011
    ..The purpose of this study was to determine the incidence of neck metastasis in hard palate and maxillary alveolus squamous cell carcinoma (SCC) and to identify factors predictive of regional failure...
  7. pmc Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 136:697-701. 2010
    ..Outcomes of oral cancer in pediatric patients have not been studied, to our knowledge...
  8. doi request reprint Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
    Ian Ganly
    Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program, 1275 York Avenue, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E962-72. 2013
    ..Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis...
  9. doi request reprint Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer
    Kunal S Jain
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 119:1832-7. 2013
    ....
  10. pmc Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
    N Gopalakrishna Iyer
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:4439-46. 2011
    ..The objective of this study was to evaluate patterns of RAI use and elevated risk of secondary primary malignancies (SPM) in patients with low-risk (T1N0) WDTC...
  11. pmc The mutational landscape of adenoid cystic carcinoma
    Allen S Ho
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Nat Genet 45:791-8. 2013
    ..Collectively, our observations establish a molecular foundation for understanding and exploring new treatments for ACC. ..
  12. ncbi request reprint Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Allen S Ho
    1 Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    Thyroid 24:832-9. 2014
    ..Our objective was to determine the risk of malignancy in thyroid FNAs categorized as AUS/FLUS at a comprehensive cancer center...
  13. doi request reprint Decision making in the management of recurrent head and neck cancer
    Allen S Ho
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    Head Neck 36:144-51. 2014
    ..The decision for salvage therapy must be individualized, with management that involves well-informed patients resulting in the best outcomes...
  14. doi request reprint First bite syndrome: incidence, risk factors, treatment, and outcomes
    Gary Linkov
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Laryngoscope 122:1773-8. 2012
    ..The incidence, risk factors, treatment options, and outcomes of FBS are poorly understood. We hypothesized that certain clinical and tumor variables independently predict the development of FBS...
  15. pmc Predictors of survival in mucosal melanoma of the head and neck
    Daniel Jethanamest
    Department of Otolaryngology Head and Neck Surgery, New York University School of Medicine, New York, NY, USA
    Ann Surg Oncol 18:2748-56. 2011
    ..In order to identify factors predictive of survival, we analyzed MMHN outcomes in a large US cohort...
  16. pmc Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 20:153-8. 2010
    ..Our objective was to utilize a large cancer registry to obtain sufficient power to differentiate between outcomes in cases of TCV and PTC...
  17. doi request reprint The basis of racial differences in the incidence of thyroid cancer
    Luc G T Morris
    Head and Neck Service, Department of Otolaryngology, New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
    Ann Surg Oncol 15:1169-76. 2008
    ..The incidence of thyroid cancer in black Americans is half that in white Americans. It is unknown whether this gap represents a population difference in disease or is attributable to inferior cancer screening in the black population...
  18. ncbi request reprint Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
    Yongxing Gong
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Nat Genet 46:588-94. 2014
    ..Thus, PARK2 regulates cyclin-CDK complexes, as does the CDK inhibitor p16, but acts as a master regulator of the stability of G1/S cyclins...
  19. doi request reprint Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer
    Anuj Goenka
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 133:1214-21. 2013
    ..We conclude that patients achieving CRs after chemoradiation, based on clinical and PET/CT assessment, have a high probability of regional control, with a 2.3% regional failure rate, and may be safely observed without planned ND...
  20. pmc Outcomes of oral cavity squamous cell carcinoma in pediatric patients
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Oral Oncol 46:292-6. 2010
    ..64). Pediatric patients with OCSCC experience better survival than adult patients. When differences in patient, tumor and treatment-related characteristics are adjusted for, the two groups experience equivalent survival...
  21. doi request reprint Medullary thyroid carcinoma: ethical issues for the surgeon
    Andrew G Shuman
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2102-7. 2012
    ..We provide an overview of the ethical issues facing surgeons caring for patients with familial medullary thyroid carcinoma, and recommend interventions and resources to assist in decision making in these difficult situations...
  22. ncbi request reprint Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era
    Peter M Vila
    Department of Otolaryngology Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Eur Arch Otorhinolaryngol 271:2523-9. 2014
    ....
  23. pmc Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
    Luc G T Morris
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Nat Genet 45:253-61. 2013
    ..Loss of FAT1 function is a frequent event during oncogenesis. These findings address two outstanding issues in cancer biology: the basis of Wnt activation in non-colorectal tumors and the identity of a 4q35 tumor suppressor...
  24. pmc Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
    Luc G T Morris
    Human Oncology and Pathogenesis Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Proc Natl Acad Sci U S A 108:19024-9. 2011
    ..These findings have important implications for our understanding of head and neck cancer tumorigenesis and for the use of targeted agents for this malignancy...